New Approaches To Neuroblastoma Therapy Consortium
Clinical trials sponsored by New Approaches To Neuroblastoma Therapy Consortium, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Precision medicine trial maps genetic clues in hard-to-treat childhood cancer Results expected Dec 2026 (estimated)
- New drug cocktail aims to fight tough childhood cancer Results expected Dec 2026 (estimated)
- Immune cells take on childhood cancer in early trial Results expected Dec 2026 (estimated)
-
Immune cell boost: new hope for kids with tough neuroblastoma?
Disease control Recruiting nowThis phase 2 trial tests a new approach for children and young adults with relapsed or hard-to-treat neuroblastoma. Patients receive donor immune cells (NK cells) along with standard chemotherapy and an antibody therapy. The goal is to see if this combination can shrink tumors or…
Phase 2 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Scientists hunt for clues in neuroblastoma cells
Knowledge-focused Recruiting nowThis study collects tissue, blood, and bone marrow samples from 1,000 children with high-risk neuroblastoma. Researchers will analyze these samples to learn more about how the cancer grows and how to detect it better. The goal is to improve future treatments and monitoring of the…
Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC